ProQR Therapeutics (PRQR) Q1 2025 Earnings
PRQR·Reported May 8, 2025·Before market open
ProQR Therapeutics reported Q1 2025 revenue of $5.0M (+3.0% YoY), beat analyst consensus of $4.8M by $149.1K. Diluted EPS came in at $-0.11 (-10.0% YoY), missed the $-0.09 consensus by $0.02.
Revenue
$5.0Mbeat by $149.1K
Consensus: $4.8MDiluted EPS
$-0.11missed by $0.02
Consensus: $-0.09
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q1 2025 Earnings FAQ
Common questions about ProQR Therapeutics's Q1 2025 earnings report.
ProQR Therapeutics (PRQR) reported Q1 2025 earnings on May 8, 2025 before market open.
ProQR Therapeutics reported revenue of $5.0M and diluted EPS of $-0.11 for Q1 2025.
Revenue beat the consensus estimate of $4.8M by $149.1K. EPS missed the consensus estimate of $-0.09 by $0.02.
Compared to the same quarter a year prior, revenue grew 3.0% from $4.8M a year earlier and diluted EPS declined 10.0% from $-0.10.